SCHEMBL21154063

SCHEMBL21154063

C[C@@H]1C[C@@H](O)C(=O)[C@H](C)O1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19321820 0.67 CRBN (0.32) SMN1; SMN2
SCHEMBL165377 0.67
SCHEMBL11020381 0.65
SCHEMBL9095232 0.65
SCHEMBL22100208 0.64 SMN1; SMN2 (0.37) SMN1; SMN2
SCHEMBL27592051 0.64
SCHEMBL1705413 0.63
SCHEMBL12580876 0.62 LMNA (0.41) TSHR
SCHEMBL13559260 0.62 LMNA (0.41) TSHR
SCHEMBL13559217 0.62 LMNA (0.41) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10793590-B2 Antifungal compounds PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-10-06 US disclosed
US-20190211047-A1 ANTIFUNGAL COMPOUNDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10793590-B2 Antifungal compounds DPM1, NACA, SUCLG1 SMN1; SMN2 2190/4885TSHR 4480/4885
US-20190211047-A1 ANTIFUNGAL COMPOUNDS DPM1, NACA, SUCLG1 SMN1; SMN2 2190/4885TSHR 4480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.